APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Rifapentine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Rifapentine Market Analysis and Forecast 2026-2032

Report ID 174032960222 December 2025192 pages

Choose your research edition.

Industry ResearchRifapentine Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Rifapentine Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Rifapentine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rifapentine Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Rifapentine Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Rifapentine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Rifapentine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Rifapentine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Rifapentine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Rifapentine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Rifapentine include Changzheng Pharma, Sine Pharma, Sanofi, MED-SHINE and Foutune Pharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Rifapentine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Rifapentine, also provides the sales of main regions and countries. Of the upcoming market potential for Rifapentine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Rifapentine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Rifapentine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Rifapentine sales, projected growth trends, production technology, application and end-user industry.

Rifapentine Segment by Company

Changzheng Pharma

Sine Pharma

Sanofi

MED-SHINE

Foutune Pharma

Rifapentine Segment by Type

20 Capsules/Box

24 Capsules/Box

Rifapentine Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

Rifapentine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rifapentine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rifapentine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rifapentine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Rifapentine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Rifapentine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Rifapentine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Rifapentine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 20 Capsules/Box Major Manufacturers Table 3. 24 Capsules/Box Major Manufacturers Table 4. Global Rifapentine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Retail Pharmacies Major Manufacturers Table 6. Online Pharmacies Major Manufacturers Table 7. Hospital Pharmacies Major Manufacturers Table 8. Rifapentine Industry Trends Table 9. Rifapentine Industry Drivers Table 10. Rifapentine Industry Opportunities and Challenges Table 11. Rifapentine Industry Restraints Table 12. Global Rifapentine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Rifapentine Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Rifapentine Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Rifapentine Revenue Market Share by Region (2021-2026) Table 16. Global Rifapentine Revenue Market Share by Region (2027-2032) Table 17. Global Rifapentine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (kg) Table 18. Global Rifapentine Sales by Region (2021-2026) & (kg) Table 19. Global Rifapentine Sales by Region (2027-2032) & (kg) Table 20. Global Rifapentine Sales Market Share by Region (2021-2026) Table 21. Global Rifapentine Sales Market Share by Region (2027-2032) Table 22. Global Rifapentine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Rifapentine Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Rifapentine Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Rifapentine Sales Market Share by Manufacturers (2021-2026) Table 26. Global Rifapentine Sales Price (US$/kg) of Manufacturers (2021-2026) Table 27. Global Rifapentine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Rifapentine Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Rifapentine Manufacturers, Product Type & Application Table 30. Global Rifapentine Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Rifapentine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Rifapentine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Rifapentine Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Rifapentine Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Rifapentine Revenue Market Share by Type (2021-2026) Table 37. Global Rifapentine Revenue Market Share by Type (2027-2032) Table 38. Global Rifapentine Sales by Type 2021 VS 2025 VS 2032 (kg) Table 39. Global Rifapentine Sales by Type (2021-2026) & (kg) Table 40. Global Rifapentine Sales by Type (2027-2032) & (kg) Table 41. Global Rifapentine Sales Market Share by Type (2021-2026) Table 42. Global Rifapentine Sales Market Share by Type (2027-2032) Table 43. Global Rifapentine Price by Type (2021-2026) & (US$/kg) Table 44. Global Rifapentine Price by Type (2027-2032) & (US$/kg) Table 45. Global Rifapentine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Rifapentine Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Rifapentine Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Rifapentine Revenue Market Share by Application (2021-2026) Table 49. Global Rifapentine Revenue Market Share by Application (2027-2032) Table 50. Global Rifapentine Sales by Application 2021 VS 2025 VS 2032 (kg) Table 51. Global Rifapentine Sales by Application (2021-2026) & (kg) Table 52. Global Rifapentine Sales by Application (2027-2032) & (kg) Table 53. Global Rifapentine Sales Market Share by Application (2021-2026) Table 54. Global Rifapentine Sales Market Share by Application (2027-2032) Table 55. Global Rifapentine Price by Application (2021-2026) & (US$/kg) Table 56. Global Rifapentine Price by Application (2027-2032) & (US$/kg) Table 57. Changzheng Pharma Company Information Table 58. Changzheng Pharma Business Overview Table 59. Changzheng Pharma Rifapentine Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 60. Changzheng Pharma Rifapentine Product Portfolio Table 61. Changzheng Pharma Recent Development Table 62. Sine Pharma Company Information Table 63. Sine Pharma Business Overview Table 64. Sine Pharma Rifapentine Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 65. Sine Pharma Rifapentine Product Portfolio Table 66. Sine Pharma Recent Development Table 67. Sanofi Company Information Table 68. Sanofi Business Overview Table 69. Sanofi Rifapentine Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 70. Sanofi Rifapentine Product Portfolio Table 71. Sanofi Recent Development Table 72. MED-SHINE Company Information Table 73. MED-SHINE Business Overview Table 74. MED-SHINE Rifapentine Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 75. MED-SHINE Rifapentine Product Portfolio Table 76. MED-SHINE Recent Development Table 77. Foutune Pharma Company Information Table 78. Foutune Pharma Business Overview Table 79. Foutune Pharma Rifapentine Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 80. Foutune Pharma Rifapentine Product Portfolio Table 81. Foutune Pharma Recent Development Table 82. North America Rifapentine Revenue by Type (2021-2026) & (US$ Million) Table 83. North America Rifapentine Revenue by Type (2027-2032) & (US$ Million) Table 84. North America Rifapentine Sales by Type (2021-2026) & (kg) Table 85. North America Rifapentine Sales by Type (2027-2032) & (kg) Table 86. North America Rifapentine Sales Price by Type (2021-2026) & (US$/kg) Table 87. North America Rifapentine Sales Price by Type (2027-2032) & (US$/kg) Table 88. North America Rifapentine Revenue by Application (2021-2026) & (US$ Million) Table 89. North America Rifapentine Revenue by Application (2027-2032) & (US$ Million) Table 90. North America Rifapentine Sales by Application (2021-2026) & (kg) Table 91. North America Rifapentine Sales by Application (2027-2032) & (kg) Table 92. North America Rifapentine Sales Price by Application (2021-2026) & (US$/kg) Table 93. North America Rifapentine Sales Price by Application (2027-2032) & (US$/kg) Table 94. North America Rifapentine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. North America Rifapentine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 96. North America Rifapentine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 97. North America Rifapentine Sales by Country (2021 VS 2025 VS 2032) & (kg) Table 98. North America Rifapentine Sales by Country (2021-2026) & (kg) Table 99. North America Rifapentine Sales by Country (2027-2032) & (kg) Table 100. North America Rifapentine Sales Price by Country (2021-2026) & (US$/kg) Table 101. North America Rifapentine Sales Price by Country (2027-2032) & (US$/kg) Table 102. United States Rifapentine Revenue (2021-2032) & (US$ Million) Table 103. Canada Rifapentine Revenue (2021-2032) & (US$ Million) Table 104. Mexico Rifapentine Revenue (2021-2032) & (US$ Million) Table 105. Europe Rifapentine Revenue by Type (2021-2026) & (US$ Million) Table 106. Europe Rifapentine Revenue by Type (2027-2032) & (US$ Million) Table 107. Europe Rifapentine Sales by Type (2021-2026) & (kg) Table 108. Europe Rifapentine Sales by Type (2027-2032) & (kg) Table 109. Europe Rifapentine Sales Price by Type (2021-2026) & (US$/kg) Table 110. Europe Rifapentine Sales Price by Type (2027-2032) & (US$/kg) Table 111. Europe Rifapentine Revenue by Application (2021-2026) & (US$ Million) Table 112. Europe Rifapentine Revenue by Application (2027-2032) & (US$ Million) Table 113. Europe Rifapentine Sales by Application (2021-2026) & (kg) Table 114. Europe Rifapentine Sales by Application (2027-2032) & (kg) Table 115. Europe Rifapentine Sales Price by Application (2021-2026) & (US$/kg) Table 116. Europe Rifapentine Sales Price by Application (2027-2032) & (US$/kg) Table 117. Europe Rifapentine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 118. Europe Rifapentine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 119. Europe Rifapentine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 120. Europe Rifapentine Sales by Country (2021 VS 2025 VS 2032) & (kg) Table 121. Europe Rifapentine Sales by Country (2021-2026) & (kg) Table 122. Europe Rifapentine Sales by Country (2027-2032) & (kg) Table 123. Europe Rifapentine Sales Price by Country (2021-2026) & (US$/kg) Table 124. Europe Rifapentine Sales Price by Country (2027-2032) & (US$/kg) Table 125. Germany Rifapentine Revenue (2021-2032) & (US$ Million) Table 126. France Rifapentine Revenue (2021-2032) & (US$ Million) Table 127. U.K. Rifapentine Revenue (2021-2032) & (US$ Million) Table 128. Italy Rifapentine Revenue (2021-2032) & (US$ Million) Table 129. Russia Rifapentine Revenue (2021-2032) & (US$ Million) Table 130. Spain Rifapentine Revenue (2021-2032) & (US$ Million) Table 131. Netherlands Rifapentine Revenue (2021-2032) & (US$ Million) Table 132. Switzerland Rifapentine Revenue (2021-2032) & (US$ Million) Table 133. Sweden Rifapentine Revenue (2021-2032) & (US$ Million) Table 134. Poland Rifapentine Revenue (2021-2032) & (US$ Million) Table 135. China Rifapentine Revenue by Type (2021-2026) & (US$ Million) Table 136. China Rifapentine Revenue by Type (2027-2032) & (US$ Million) Table 137. China Rifapentine Sales by Type (2021-2026) & (kg) Table 138. China Rifapentine Sales by Type (2027-2032) & (kg) Table 139. China Rifapentine Sales Price by Type (2021-2026) & (US$/kg) Table 140. China Rifapentine Sales Price by Type (2027-2032) & (US$/kg) Table 141. China Rifapentine Revenue by Application (2021-2026) & (US$ Million) Table 142. China Rifapentine Revenue by Application (2027-2032) & (US$ Million) Table 143. China Rifapentine Sales by Application (2021-2026) & (kg) Table 144. China Rifapentine Sales by Application (2027-2032) & (kg) Table 145. China Rifapentine Sales Price by Application (2021-2026) & (US$/kg) Table 146. China Rifapentine Sales Price by Application (2027-2032) & (US$/kg) Table 147. Asia Rifapentine Revenue by Type (2021-2026) & (US$ Million) Table 148. Asia Rifapentine Revenue by Type (2027-2032) & (US$ Million) Table 149. Asia Rifapentine Sales by Type (2021-2026) & (kg) Table 150. Asia Rifapentine Sales by Type (2027-2032) & (kg) Table 151. Asia Rifapentine Sales Price by Type (2021-2026) & (US$/kg) Table 152. Asia Rifapentine Sales Price by Type (2027-2032) & (US$/kg) Table 153. Asia Rifapentine Revenue by Application (2021-2026) & (US$ Million) Table 154. Asia Rifapentine Revenue by Application (2027-2032) & (US$ Million) Table 155. Asia Rifapentine Sales by Application (2021-2026) & (kg) Table 156. Asia Rifapentine Sales by Application (2027-2032) & (kg) Table 157. Asia Rifapentine Sales Price by Application (2021-2026) & (US$/kg) Table 158. Asia Rifapentine Sales Price by Application (2027-2032) & (US$/kg) Table 159. Asia Rifapentine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 160. Asia Rifapentine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 161. Asia Rifapentine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 162. Asia Rifapentine Sales by Country (2021 VS 2025 VS 2032) & (kg) Table 163. Asia Rifapentine Sales by Country (2021-2026) & (kg) Table 164. Asia Rifapentine Sales by Country (2027-2032) & (kg) Table 165. Asia Rifapentine Sales Price by Country (2021-2026) & (US$/kg) Table 166. Asia Rifapentine Sales Price by Country (2027-2032) & (US$/kg) Table 167. Japan Rifapentine Revenue (2021-2032) & (US$ Million) Table 168. South Korea Rifapentine Revenue (2021-2032) & (US$ Million) Table 169. India Rifapentine Revenue (2021-2032) & (US$ Million) Table 170. Australia Rifapentine Revenue (2021-2032) & (US$ Million) Table 171. Taiwan Rifapentine Revenue (2021-2032) & (US$ Million) Table 172. Southeast Asia Rifapentine Revenue (2021-2032) & (US$ Million) Table 173. SAMEA Rifapentine Revenue by Type (2021-2026) & (US$ Million) Table 174. SAMEA Rifapentine Revenue by Type (2027-2032) & (US$ Million) Table 175. SAMEA Rifapentine Sales by Type (2021-2026) & (kg) Table 176. SAMEA Rifapentine Sales by Type (2027-2032) & (kg) Table 177. SAMEA Rifapentine Sales Price by Type (2021-2026) & (US$/kg) Table 178. SAMEA Rifapentine Sales Price by Type (2027-2032) & (US$/kg) Table 179. SAMEA Rifapentine Revenue by Application (2021-2026) & (US$ Million) Table 180. SAMEA Rifapentine Revenue by Application (2027-2032) & (US$ Million) Table 181. SAMEA Rifapentine Sales by Application (2021-2026) & (kg) Table 182. SAMEA Rifapentine Sales by Application (2027-2032) & (kg) Table 183. SAMEA Rifapentine Sales Price by Application (2021-2026) & (US$/kg) Table 184. SAMEA Rifapentine Sales Price by Application (2027-2032) & (US$/kg) Table 185. SAMEA Rifapentine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 186. SAMEA Rifapentine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 187. SAMEA Rifapentine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 188. SAMEA Rifapentine Sales by Country (2021 VS 2025 VS 2032) & (kg) Table 189. SAMEA Rifapentine Sales by Country (2021-2026) & (kg) Table 190. SAMEA Rifapentine Sales by Country (2027-2032) & (kg) Table 191. SAMEA Rifapentine Sales Price by Country (2021-2026) & (US$/kg) Table 192. SAMEA Rifapentine Sales Price by Country (2027-2032) & (US$/kg) Table 193. Brazil Rifapentine Revenue (2021-2032) & (US$ Million) Table 194. Argentina Rifapentine Revenue (2021-2032) & (US$ Million) Table 195. Chile Rifapentine Revenue (2021-2032) & (US$ Million) Table 196. Colombia Rifapentine Revenue (2021-2032) & (US$ Million) Table 197. Peru Rifapentine Revenue (2021-2032) & (US$ Million) Table 198. Saudi Arabia Rifapentine Revenue (2021-2032) & (US$ Million) Table 199. Israel Rifapentine Revenue (2021-2032) & (US$ Million) Table 200. UAE Rifapentine Revenue (2021-2032) & (US$ Million) Table 201. Turkey Rifapentine Revenue (2021-2032) & (US$ Million) Table 202. Iran Rifapentine Revenue (2021-2032) & (US$ Million) Table 203. Egypt Rifapentine Revenue (2021-2032) & (US$ Million) Table 204. Key Raw Materials Table 205. Raw Materials Key Suppliers Table 206. Rifapentine Distributors List Table 207. Rifapentine Customers List Table 208. Research Programs/Design for This Report Table 209. Authors List of This Report Table 210. Secondary Sources Table 211. Primary Sources List of Figures Figure 1. Rifapentine Image Figure 2. Global Rifapentine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Rifapentine Market Size Share 2021 VS 2025 VS 2032 Figure 4. 20 Capsules/Box Image Figure 5. 24 Capsules/Box Image Figure 6. Global Rifapentine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Rifapentine Market Size Share 2021 VS 2025 VS 2032 Figure 8. Retail Pharmacies Image Figure 9. Online Pharmacies Image Figure 10. Hospital Pharmacies Image Figure 11. Global Rifapentine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Rifapentine Revenue (2021-2032) & (US$ Million) Figure 13. Global Rifapentine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Rifapentine Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Rifapentine Revenue Market Share by Region (2021-2032) Figure 16. Global Rifapentine Sales (2021-2032) & (kg) Figure 17. Global Rifapentine Sales by Region: 2021 VS 2025 VS 2032 (kg) Figure 18. Global Rifapentine Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Rifapentine Sales YoY (2021-2032) & (kg) Figure 20. Europe Rifapentine Sales YoY (2021-2032) & (kg) Figure 21. China Rifapentine Sales YoY (2021-2032) & (kg) Figure 22. Asia (Excluding China) Rifapentine Sales YoY (2021-2032) & (kg) Figure 23. South America, Middle East and Africa Rifapentine Sales YoY (2021-2032) & (kg) Figure 24. Global Rifapentine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Rifapentine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Rifapentine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Rifapentine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Rifapentine Revenue Market Share by Type (2021-2032) Figure 30. Global Rifapentine Sales by Type (2021 VS 2025 VS 2032) & (kg) Figure 31. Global Rifapentine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Rifapentine Sales Market Share by Type (2021-2032) Figure 33. Global Rifapentine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Rifapentine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Rifapentine Revenue Market Share by Application (2021-2032) Figure 36. Global Rifapentine Sales by Application (2021 VS 2025 VS 2032) & (kg) Figure 37. Global Rifapentine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Rifapentine Sales Market Share by Application (2021-2032) Figure 39. North America Rifapentine Revenue Share by Type (2021-2032) Figure 40. North America Rifapentine Sales Share by Type (2021-2032) Figure 41. North America Rifapentine Revenue Share by Application (2021-2032) Figure 42. North America Rifapentine Sales Share by Application (2021-2032) Figure 43. North America Rifapentine Revenue Share by Country (2021-2032) Figure 44. North America Rifapentine Sales Share by Country (2021-2032) Figure 45. Europe Rifapentine Revenue Share by Type (2021-2032) Figure 46. Europe Rifapentine Sales Share by Type (2021-2032) Figure 47. Europe Rifapentine Revenue Share by Application (2021-2032) Figure 48. Europe Rifapentine Sales Share by Application (2021-2032) Figure 49. Europe Rifapentine Revenue Share by Country (2021-2032) Figure 50. Europe Rifapentine Sales Share by Country (2021-2032) Figure 51. China Rifapentine Revenue Share by Type (2021-2032) Figure 52. China Rifapentine Sales Share by Type (2021-2032) Figure 53. China Rifapentine Revenue Share by Application (2021-2032) Figure 54. China Rifapentine Sales Share by Application (2021-2032) Figure 55. Asia Rifapentine Revenue Share by Type (2021-2032) Figure 56. Asia Rifapentine Sales Share by Type (2021-2032) Figure 57. Asia Rifapentine Revenue Share by Application (2021-2032) Figure 58. Asia Rifapentine Sales Share by Application (2021-2032) Figure 59. Asia Rifapentine Revenue Share by Country (2021-2032) Figure 60. Asia Rifapentine Sales Share by Country (2021-2032) Figure 61. SAMEA Rifapentine Revenue Share by Type (2021-2032) Figure 62. SAMEA Rifapentine Sales Share by Type (2021-2032) Figure 63. SAMEA Rifapentine Revenue Share by Application (2021-2032) Figure 64. SAMEA Rifapentine Sales Share by Application (2021-2032) Figure 65. SAMEA Rifapentine Revenue Share by Country (2021-2032) Figure 66. SAMEA Rifapentine Sales Share by Country (2021-2032) Figure 67. Rifapentine Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Rifapentine Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 20 Capsules/Box
  • 24 Capsules/Box
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
Companies covered
  • Changzheng Pharma
  • Sine Pharma
  • Sanofi
  • MED-SHINE
  • Foutune Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Rifapentine Market by Type
  3. 1.2.1 Global Rifapentine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 20 Capsules/Box
  5. 1.2.3 24 Capsules/Box
  6. 1.3 Rifapentine Market by Application
  7. 1.3.1 Global Rifapentine Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Retail Pharmacies
  9. 1.3.3 Online Pharmacies
  10. 1.3.4 Hospital Pharmacies
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Rifapentine Market Dynamics
  1. 2.1 Rifapentine Industry Trends
  2. 2.2 Rifapentine Industry Drivers
  3. 2.3 Rifapentine Industry Opportunities and Challenges
  4. 2.4 Rifapentine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Rifapentine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Rifapentine Revenue by Region
  3. 3.2.1 Global Rifapentine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Rifapentine Revenue by Region (2021-2026)
  5. 3.2.3 Global Rifapentine Revenue by Region (2027-2032)
  6. 3.2.4 Global Rifapentine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Rifapentine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Rifapentine Sales by Region
  9. 3.4.1 Global Rifapentine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Rifapentine Sales by Region (2021-2026)
  11. 3.4.3 Global Rifapentine Sales by Region (2027-2032)
  12. 3.4.4 Global Rifapentine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Rifapentine Revenue by Manufacturers
  2. 4.1.1 Global Rifapentine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Rifapentine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Rifapentine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Rifapentine Sales by Manufacturers
  6. 4.2.1 Global Rifapentine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Rifapentine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Rifapentine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Rifapentine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Rifapentine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Rifapentine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Rifapentine Manufacturers, Product Type & Application
  13. 4.7 Global Rifapentine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Rifapentine Market CR5 and HHI
  16. 4.8.2 2025 Rifapentine Tier 1, Tier 2, and Tier 3
5 Rifapentine Market by Type
  1. 5.1 Global Rifapentine Revenue by Type
  2. 5.1.1 Global Rifapentine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Rifapentine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Rifapentine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Rifapentine Sales by Type
  6. 5.2.1 Global Rifapentine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Rifapentine Sales by Type (2021-2032) & (kg)
  8. 5.2.3 Global Rifapentine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Rifapentine Price by Type
6 Rifapentine Market by Application
  1. 6.1 Global Rifapentine Revenue by Application
  2. 6.1.1 Global Rifapentine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Rifapentine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Rifapentine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Rifapentine Sales by Application
  6. 6.2.1 Global Rifapentine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Rifapentine Sales by Application (2021-2032) & (kg)
  8. 6.2.3 Global Rifapentine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Rifapentine Price by Application
7 Company Profiles
  1. 7.1 Changzheng Pharma
  2. 7.1.1 Changzheng Pharma Company Information
  3. 7.1.2 Changzheng Pharma Business Overview
  4. 7.1.3 Changzheng Pharma Rifapentine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Changzheng Pharma Rifapentine Product Portfolio
  6. 7.1.5 Changzheng Pharma Recent Developments
  7. 7.2 Sine Pharma
  8. 7.2.1 Sine Pharma Company Information
  9. 7.2.2 Sine Pharma Business Overview
  10. 7.2.3 Sine Pharma Rifapentine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sine Pharma Rifapentine Product Portfolio
  12. 7.2.5 Sine Pharma Recent Developments
  13. 7.3 Sanofi
  14. 7.3.1 Sanofi Company Information
  15. 7.3.2 Sanofi Business Overview
  16. 7.3.3 Sanofi Rifapentine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Sanofi Rifapentine Product Portfolio
  18. 7.3.5 Sanofi Recent Developments
  19. 7.4 MED-SHINE
  20. 7.4.1 MED-SHINE Company Information
  21. 7.4.2 MED-SHINE Business Overview
  22. 7.4.3 MED-SHINE Rifapentine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 MED-SHINE Rifapentine Product Portfolio
  24. 7.4.5 MED-SHINE Recent Developments
  25. 7.5 Foutune Pharma
  26. 7.5.1 Foutune Pharma Company Information
  27. 7.5.2 Foutune Pharma Business Overview
  28. 7.5.3 Foutune Pharma Rifapentine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Foutune Pharma Rifapentine Product Portfolio
  30. 7.5.5 Foutune Pharma Recent Developments
8 North America
  1. 8.1 North America Rifapentine Market Size by Type
  2. 8.1.1 North America Rifapentine Revenue by Type (2021-2032)
  3. 8.1.2 North America Rifapentine Sales by Type (2021-2032)
  4. 8.1.3 North America Rifapentine Price by Type (2021-2032)
  5. 8.2 North America Rifapentine Market Size by Application
  6. 8.2.1 North America Rifapentine Revenue by Application (2021-2032)
  7. 8.2.2 North America Rifapentine Sales by Application (2021-2032)
  8. 8.2.3 North America Rifapentine Price by Application (2021-2032)
  9. 8.3 North America Rifapentine Market Size by Country
  10. 8.3.1 North America Rifapentine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Rifapentine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Rifapentine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Rifapentine Market Size by Type
  2. 9.1.1 Europe Rifapentine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Rifapentine Sales by Type (2021-2032)
  4. 9.1.3 Europe Rifapentine Price by Type (2021-2032)
  5. 9.2 Europe Rifapentine Market Size by Application
  6. 9.2.1 Europe Rifapentine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Rifapentine Sales by Application (2021-2032)
  8. 9.2.3 Europe Rifapentine Price by Application (2021-2032)
  9. 9.3 Europe Rifapentine Market Size by Country
  10. 9.3.1 Europe Rifapentine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Rifapentine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Rifapentine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Rifapentine Market Size by Type
  2. 10.1.1 China Rifapentine Revenue by Type (2021-2032)
  3. 10.1.2 China Rifapentine Sales by Type (2021-2032)
  4. 10.1.3 China Rifapentine Price by Type (2021-2032)
  5. 10.2 China Rifapentine Market Size by Application
  6. 10.2.1 China Rifapentine Revenue by Application (2021-2032)
  7. 10.2.2 China Rifapentine Sales by Application (2021-2032)
  8. 10.2.3 China Rifapentine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Rifapentine Market Size by Type
  2. 11.1.1 Asia Rifapentine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Rifapentine Sales by Type (2021-2032)
  4. 11.1.3 Asia Rifapentine Price by Type (2021-2032)
  5. 11.2 Asia Rifapentine Market Size by Application
  6. 11.2.1 Asia Rifapentine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Rifapentine Sales by Application (2021-2032)
  8. 11.2.3 Asia Rifapentine Price by Application (2021-2032)
  9. 11.3 Asia Rifapentine Market Size by Country
  10. 11.3.1 Asia Rifapentine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Rifapentine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Rifapentine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Rifapentine Market Size by Type
  2. 12.1.1 SAMEA Rifapentine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Rifapentine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Rifapentine Price by Type (2021-2032)
  5. 12.2 SAMEA Rifapentine Market Size by Application
  6. 12.2.1 SAMEA Rifapentine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Rifapentine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Rifapentine Price by Application (2021-2032)
  9. 12.3 SAMEA Rifapentine Market Size by Country
  10. 12.3.1 SAMEA Rifapentine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Rifapentine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Rifapentine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Rifapentine Value Chain Analysis
  2. 13.1.1 Rifapentine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Rifapentine Production Mode & Process
  6. 13.2 Rifapentine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Rifapentine Distributors
  9. 13.2.3 Rifapentine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst